A recent study of NAFLD discovered that ARID2 stimulates JAK2 ubiquitination, which is achieved via recruiting CARM1 to enhance H3R17me2a levels at the NEDD4L promoter and upregulate NEDD4L expression, a novel E3 ligase for JAK2. Here, JAK2 is linked to metabolic dysfunction-associated steatotic liver disease.